Form 4: Century Therapeutics Officer Sells Shares to Cover Tax Obligations

Adrienne Farid, Chief Operations Officer of Century Therapeutics, sold 1,054 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 3, 2025, Adrienne Farid, the Chief Operations Officer of Century Therapeutics, sold 1,054 shares of the company's common stock.
• The sale was executed at a price of $0.78 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Farid directly owns 134,076 shares of Century Therapeutics.
• The sale was automatic and not at the discretion of the reporting person.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment as it reports a routine transaction (sale of shares to cover tax obligations). It doesn't indicate any positive or negative developments for the company.

Future Outlook

There are no forward-looking statements in this document.

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by an officer could have a minor, temporary impact on the stock price, but it's unlikely to be significant since it's for tax obligations.

Key Dates

Keywords

Century Therapeutics, Insider Trading, Form 4, Stock Sale, Adrienne Farid, Tax Obligations, Restricted Stock Units, IPSC, Chief Operations Officer